HIV vaccine study uncovers powerful new antibody target Certain antibodies blocked nearly 70% of HIV strains, including those typically hard to target.
May 27, 2025
LA JOLLA, CA In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies capable of blocking a wide range of HIV strains including those that are typically the hardest to stop.
Published in Immunity on May 7, 2025, the research comes from a collaboration led by scientists at Scripps Research and Sweden's Karolinska Institute. Their results mark a strong demonstration that broadly neutralizing antibodies (bNAbs) long considered a key goal for HIV vaccination can be successfully induced in nonhuman primates. It also points to a new target on the HIV spike protein that future antibodies may be able to successfully bind to block the virus.
What sets this work apart is that we didn't just see initial signs of a promising response; we actually isolated functional broadly neutralizing antibodies and pinpointed exactly where they bind on the surface of the virus, says senior author Richard Wyatt, professor in the Department of Immunology and Microbiology at Scripps Research. This tells us not only that the approach works, but also specifically why it works.
Because HIV rapidly mutates and there are literally millions of different strains circulating in humans around the world, scientists have focused their research efforts on creating vaccines that can stimulate the body to produce bNAbs that simultaneously recognize many strains at once. While some people spontaneously produce bNAbs after exposure to HIV, it has been a challenge to create a vaccine that reliably induces bNAbs in nonhuman primates or humans.
A two-step strategy
In the new work, Wyatt and his team first designed a mimic for the HIV spike protein a key section of HIV's machinery that antibodies target to block infection. Unlike earlier designs, the new spike mimics don't fall apart after injection and closely resemble the HIV spike protein's structure.
Then, the group turned to a two-step vaccination strategy. First, they primed the immune system with a version of the spike mimic that lacked key sugar molecules, which normally coat the protein and make it harder to recognize. This helped expose a critical, conserved region of the spike: the CD4 binding site, where the spike protein attaches to human immune cells.
After two sequential doses of the priming vaccine, five boosters were administered, each about twelve weeks apart. This booster series of spike proteins from different HIV strains now with their sugar coat intact retrained the immune system to recognize the same region even when it was partially hidden.
The deliberate sequence of vaccines, the researchers say, was key to success. We weren't just vaccinating at random, says Javier Guenaga, a senior staff scientist at Scripps Research and co-first author of the new paper. This was a rational, structure-guided approach to elicit the right kinds of antibodies.
Encouraging results
The approach paid off. Several of the vaccinated animal models produced antibodies that could neutralize tier 2 HIV strains, which are among the hardest to block. From one animal model, researchers isolated a family of antibodies, named LJF-0034, that neutralized nearly 70% of a global panel of 84 HIV strains.
It is incredibly exciting to see a vaccine generate this kind of breadth in nonhuman primates, says senior staff scientist Shridhar Bale, a co-first author of the work. And it's not just a one-off. We saw responses targeting this site in multiple animals.
The group then showed that antibodies like LJF-0034 bound to a previously undescribed site on the virus, bridging two sections of the spike protein. Future research can help guide the development of additional vaccines targeting this new, promising site. Wyatt says his team would like to optimize the vaccine so that it can reliably elicit LJF-0034-like responses in a greater fraction of recipients.
Ultimately, an effective HIV vaccine regimen will likely include a combination of vaccines that yield different bNAbs, all acting together.
This is far from a final vaccine, says Wyatt. But having a new, highly effective target is incredibly exciting and will help shape our efforts moving forward.
One vaccine candidate used in this study is already being tested in a phase 1 clinical trial, with early results expected soon. In that trial, human participants are receiving the same spike protein (lacking sugar molecules) used as the priming vaccine in this study.
In addition to Wyatt, Bale, and Guenaga, authors of the study, Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer, include Richard Wilson, Jocelyn Cluff, Esmeralda D. Doyle, Gabriel Ozorowski, Xiaohe Lin, Leigh M. Sewall, Wen-Hsin Lee, Shiyu Zhang, Ian A. Wilson, and Andrew B. Ward of Scripps Research; Fabian-Alexander Schleich, Monika dori, Xaquin Castro Dopico, Mark Chernyshev, Alma Teresia Cotgreave, Marco Mandolesi, Martin Corcoran, and Gunilla B. Karlsson Hedestam of the Karolinska Institutet; Sijy O'Dell and Nicole A. Doria-Rose of the National Institute of Allergy and Infectious Diseases; Brandon S. Healy, Deuk Lim, Vanessa R. Lewis, Diane Carnathan, and Guido Silvestri of Emory University; and Elana Ben-Akiva and Darrell J. Irvine of the Massachusetts Institute of Technology.
This work was supported by funding from HIVRAD (P01 AI104722, P01 AI157299, P01 AI124337), Scripps CHAVD (UM1 AI144462), the James B. Pendleton Trust, the Swedish Research Council (2017-00968) and the Emory National Primate Research Center (ORIP/ODP51OD011132,
Europe Stories
04/09/2025
Monumental Sports & Entertainment (MSE), in collaboration with Dalet, has been a...
29/05/2025
Japan's music scene is entering an exciting new chapter. Long known for its ...
29/05/2025
Webinar and Report: State Broadband Rate Regulation
May 29, 2025
Network Economics
News
Cartesian presents key findings from our latest report for...
29/05/2025
We're pleased to be working with Nectar360 (Sainsbury's retail media business) and Albert Heijn, who are in the latter stages of the compliance audit an...
29/05/2025
May 29 2025, 23:30 (PDT) Mahindra Thar ROXX brings Dolby Atmos for an elevated entertainment experience
First to the world: 4-channel immersive audio with D...
29/05/2025
LONDON - 29th May 2025: Fifty years ago, The Good Life made its debut. Now, the ...
29/05/2025
Comscore Adds Consumer AI Tool Usage Data to Its Industry-Leading Suite of Repor...
29/05/2025
Apple today introduced new Logic Pro updates for Mac and iPad, supercharging beat making and producing. The innovative Stem Splitter feature now offers even gre...
29/05/2025
Dragon Hearts- RT documentary follows cancer survivors united through the power...
29/05/2025
2FM is hitting the road this summer, broadcasting live from Ireland's biggest music festivals, starting with Forbidden Fruit this June Bank Holiday weekend....
29/05/2025
Aistear an Amhr in RT series reveals fascinating stories behind Ireland's ...
28/05/2025
Spotify is all about bringing you closer to the voices and stories you love. Tha...
28/05/2025
A ind stria musical do Brasil est passando por uma transforma o hist rica - e o Spotify segue iluminando esse caminho. A vers o mais recente do relat rio Loud...
28/05/2025
Brazil's music industry is in the midst of a historic transformation-and Spotify continues to help illuminate the path. Our most recent Loud & Clear report,...
28/05/2025
Spotify's commitment to transparency and artist empowerment continues to res...
28/05/2025
VIZ Media Confirms Acquisition of One-Punch Man Season 3
San Francisco, CA May 27, 2025 VIZ Media Get ready, heroes! VIZ Media is excited to officially...
28/05/2025
SAN JOSE, Calif. - May 28, 2025 - Harmonic (NASDAQ: HLIT) today announced the launch of its new SeaStar Optical Node, redefining broadband connectivity for low...
28/05/2025
Yahoo DSP Onboards Comscore's AI-Powered ID-Free Audiences for Efficient and...
28/05/2025
This summer, RT , in collaboration with Ireland's vibrant independent produc...
28/05/2025
Debbie Brophy has been crowned the winner of Super Garden 2025. The garden design challenge, now in its 16th series, has once again showcased the extraordinary ...
27/05/2025
aconnic AG (ISIN: DE000A0LBKW6), Munich, published the 2024 Corporate Carbon Foo...
27/05/2025
Since launching in 2008, the App Store has been a safe and trusted place for users and a vibrant marketplace for developers to grow their businesses around the ...
27/05/2025
RT is pleased to announce the appointment of Hugh Ormond to the new role, Head of Podcasting, following an internal competition.
In this pivotal role to the ...
27/05/2025
RT will meet with the Joint Oireachtas Committee for Arts, Media, Communications, Culture and Sport on Wednesday 28th May, 2025.
The Committee identified a nu...
27/05/2025
May 27 2025, 07:00 (PDT) TCL Brings Dolby Atmos FlexConnect to 2025 QD-Mini LED TVs
Dolby Atmos FlexConnect to power forthcoming wireless speaker through t...
23/05/2025
New 5G satellite technology by an international research team advances global mo...
23/05/2025
In an email to RT staff this evening, RT Director General stated as follows:
Dear colleagues,
RT 's VEP 2025 is now closed. I can confirm that we receiv...
23/05/2025
23 May 2025
VEON and Engro Corporation Advance to Closing Pioneering Infrastruc...
23/05/2025
Featuring guest writers Edel Coffey, Mike McCormack, Sin ad Moriarty, Dave Rudde...
22/05/2025
Calrec fuels young talent by backing local students in the F1 in Schools programme...
22/05/2025
Secure integrated multi-orbit network (SIMON ) delivered by SES Space & Defense ...
22/05/2025
Zurich Instruments and Rohde & Schwarz to back the National Quantum Computing Te...
22/05/2025
Rohde & Schwarz Satellite Industry Day 2025: Connecting the world with New Space...
22/05/2025
Wuppertal May 22, 2025
Riedel Premieres Easy5G and RefCam Live Systems in High...
22/05/2025
SAN JOSE, Calif. - May 22, 2025 - Harmonic (NASDAQ: HLIT) today announced that t...
22/05/2025
Introducing RedNet TNX We're pleased to introduce RedNet TNX, the latest addition to the RedNet range and our first Thunderbolt interface specifically de...
22/05/2025
In line with the published New Direction strategy, RT has launched a commissioning process that will see all Christian Worship content on RT 's video platf...
22/05/2025
Facebook
Twitter
LinkedIn
As a strategic partner in helping Malaysia achie...
22/05/2025
Prime Time speaks to Charleen Murphy, an influencer whose online harassment turned into a real-world attack
Tonight, Prime Time hosts a special programme focus...
22/05/2025
RT 's Today show, in conjunction with Ireland's oldest publishing house Mercier Press, have announced Ireland's newest published author. Rebecca M...
21/05/2025
When CMA Fest springs to life in Nashville each year, Spotify House is always one of the top destinations-and 2025 will be no different. For the sixth year, Spo...
21/05/2025
Marking a first, Spotify has launched the Upcoming Releases hub-a destination so...
21/05/2025
At todays Annual General Meeting, the shareholders of SGL Carbon SE discharged the Board of Management and Supervisory Board for the 2024 fiscal year and approv...
21/05/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
21/05/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
21/05/2025
Wednesday 21 May 2025
Brits call for voice notes to be capped at two minutes after research reveals the nation is suffering from VNF - Voice Note Fatigue Voice...
21/05/2025
ElastiFlow and Rohde & Schwarz collaborate to deliver unmatched network traffic ...
21/05/2025
Arvato Systems Receives Gold Award at Service Provider Award in the Category AI...
HIV vaccine study uncovers powerful new antibody target Certain antibodies blocked nearly 70% of HIV strains, including those typically hard to target.
